<--- Back to Details
First PageDocument Content
Hospice / Healthcare in the United States / Palliative care / Amyotrophic lateral sclerosis / Hospice care in the United States / Hospice Journey / Medicine / Health / Palliative medicine
Date: 2009-11-09 19:01:45
Hospice
Healthcare in the United States
Palliative care
Amyotrophic lateral sclerosis
Hospice care in the United States
Hospice Journey
Medicine
Health
Palliative medicine

DRAFT Advanced Illness Management (AIM Program) A Program of Sutter VNA & Hospice Transition Questions

Add to Reading List

Source URL: www.promotingexcellence.org

Download Document from Source Website

File Size: 50,45 KB

Share Document on Facebook

Similar Documents

Amyotrophic lateral sclerosis (ALS) is a chronic relentless neurodegenerative disorder and it is the most common motor neuron disorder of the adult life

Amyotrophic lateral sclerosis (ALS) is a chronic relentless neurodegenerative disorder and it is the most common motor neuron disorder of the adult life

DocID: 1sGJy - View Document

New NIH guidelines to improve Experimental Rigor and Reproducibility Oswald Steward Professor, Department of Anatomy & Neurobiology Senior Associate Dean for Research University of California School of Medicine

New NIH guidelines to improve Experimental Rigor and Reproducibility Oswald Steward Professor, Department of Anatomy & Neurobiology Senior Associate Dean for Research University of California School of Medicine

DocID: 1rjyT - View Document

...................................  OCCUPATIONAL Therapy Overcome your limitations.

................................... OCCUPATIONAL Therapy Overcome your limitations.

DocID: 1qQof - View Document

Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis

Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis

DocID: 1qMIa - View Document

Sarah Ayer 311 Thornton Drive Franklin, TX0000 January 31, 1999 David McMurrey

Sarah Ayer 311 Thornton Drive Franklin, TX0000 January 31, 1999 David McMurrey

DocID: 1qFos - View Document